Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

The Nordic Myeloma Study Group conducted an open randomized trial to compare bortezomib as consolidation therapy given after high-dose therapy and autologous stem cell transplantation (ASCT) with no consolidation in bortezomib-naive patients with newly diagnosed multiple myeloma. Overall, 370 patien...

詳細記述

保存先:
書誌詳細
主要な著者: Mellqvist, Ulf-Henrik, Gimsing, Peter, Hjertner, Oyvind, Lenhoff, Stig, Laane, Edward, Remes, Kari, Steingrimsdottir, Hlif, Abildgaard, Niels, Ahlberg, Lucia, Blimark, Cecilie, Dahl, Inger Marie, Forsberg, Karin, Gedde-Dahl, Tobias, Gregersen, Henrik, Gruber, Astrid, Guldbrandsen, Nina, Haukås, Einar, Carlson, Kristina, Kvam, Ann Kristin, Nahi, Hareth, Lindås, Roald, Andersen, Niels Frost, Turesson, Ingemar, Waage, Anders, Westin, Jan, Frost Andersen, Niels, Toffner-Clausen, Nilsaage, Silvennoinen, Raija, Kristin Kvam, Ann, Marie Dahl, Inger, Linder, Olle
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2013
主題:
Clinical Trials and Observations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674665/
https://ncbi.nlm.nih.gov/pubmed/23616624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-11-464503
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料